Update on breast implants and the risk of anaplastic large cell lymphoma

31 Jan 2020

Dr Jane Deacon

by Dr Jane Deacon

Wheeling a patient to surgery

The Therapeutic Goods Administration (TGA) recently published the outcome from its review of breast implants and breast tissue expanders in Australia. The evidence available at present suggests that breast implant associated anaplastic large cell lymphoma (BIA-ALCL) is more likely to occur in implants with a greater surface area and roughness (macro-textured). Therefore, some breast implant devices have been suspended, and the full list is available on the TGA website.

The suspensions do not affect the supply of the smooth implants available and to date there are no known cases of BIA-ALCL in Australia where only smooth devices have been implanted.

There are new conditions associated with use of breast implant devices. These include making patients aware of the warning and risks associated with the product used, and the risk of BIA-ALCL, as well as enhanced reporting of adverse events and timely reporting of all cases of BIA-ALCL to the TGA.

Information for patients on the TGA website now includes an informative Q and A video.

Not yet subscribed to receive our medico-legal blog? Scroll down to subscribe and stay connected.

This blog contains general information only. We recommend you contact your medical defence organisation or insurer when you require specific advice in relation to medico-legal matters.



Doctors Let's Talk: Get Yourself A Fricking GP

Get yourself a fricking GP stat! is a conversation with Dr Lam, 2019 RACGP National General Practitioner of the Year, rural GP and GP Anesthetics trainee, that explores the importance of finding your own GP as a Junior Doctor.


25 Oct 2022

Systematic efforts to reduce harms due to prescribed opioids – webinar recording

Efforts are underway across the healthcare system to reduce harms caused by pharmaceutical opioids. This 43-min recording of a live webinar, delivered 11 March 2021, is an opportunity for prescribers to check, and potentially improve, their contribution to these endeavours. Hear from an expert panel about recent opioid reforms by the Therapeutic Goods Administration and changes to the Pharmaceutical Benefits Scheme. 

Diplomacy in a hierarchy: tips for approaching a difficult conversation

Have you found yourself wondering how to broach a tough topic of conversation? It can be challenging to effectively navigate a disagreement with a co-worker, especially if they're 'above' you; however, it's vital for positive team dynamics and safe patient care. In this recording of a live webinar you'll have the opportunity to learn from colleagues' experiences around difficult discussions and hear from a diverse panel moderated by Dr Kiely Kim (medico-legal adviser and general practitioner). Recorded live on 2 September 2020.